Serum galectin-3 levels in patients with nonalcoholic fatty liver disease


YILMAZ Y., EREN F., Kurt R., Yonal O., Polat Z., Senates E., ...More

CLINICAL BIOCHEMISTRY, vol.44, no.12, pp.955-958, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 12
  • Publication Date: 2011
  • Doi Number: 10.1016/j.clinbiochem.2011.05.015
  • Journal Name: CLINICAL BIOCHEMISTRY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.955-958
  • Keywords: Galectin-3, Nonalcoholic fatty liver disease, Enzyme-linked immunosorbent assay, Biopsy, METABOLIC SYNDROME, STEATOHEPATITIS, ASSOCIATION, OBESITY, MICE

Abstract

Objectives: Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes.